Research Article

Biocatalytic Enantioselective Synthesis of Chiral Amines Using Immobilized Transaminases in a Microfluidic Reactor System for Pharmaceutical Precursors

123 reads
J Ong Biosci, 2026, 1 (2), 117-123, ISSN

Abstract

Optically pure chiral amines represent ubiquitous pharmacophores in the synthesis of pharmaceuticals, agrochemicals, and fine chemical intermediates. While ω-transaminases (ω-TAs) offer an environmentally benign and stereochemically superior route to these molecules, batch biocatalysis is frequently hampered by thermodynamic equilibrium constraints, severe product inhibition, and limited operational enzyme stability. In this study, an engineered (S)-selective ω-transaminase from Chromobacterium violaceum was covalently immobilized onto glutaraldehyde-functionalized magnetic core-shell mesoporous silica nanoparticles (M-MSNs) and incorporated into a continuous-flow packed-bed microfluidic reactor. The immobilized biocatalytic nanocomposite exhibited an immobilization efficiency of 88.4% and maintained over 82% of its native catalytic activity. Under continuous-flow microfluidic operation, residence times were systematically optimized between 5 and 45 minutes for the asymmetric amination of various prochiral ketones, utilizing isopropylamine as an abundant amine donor. The microreactor system achieved remarkable conversions of up to 96.2% with exceptional enantioselectivity (>99% ee) for model pharmaceutical precursors, including (S)-1-phenylethylamine and fluorinated phenylpropan-2-amine derivatives. Continuous operation for 72 hours revealed superior catalytic durability, retaining >90% of initial conversion without significant leaching or pressure drop. The platform yielded a space-time yield of 48.6 g·L-1·h-1, outperforming conventional batch reactors by an order of magnitude. These findings demonstrate that coupling nanostructured biocatalysts with microfluidic process intensification provides a robust, scalable pathway for the continuous asymmetric synthesis of pharmaceutical building blocks.

Keywords Biocatalysis enzyme immobilization Chiral amines Transaminases Microfluidic reactor
Authors 3

The team behind this paper

3 authors, 3 institutions.

This paper Kwame Nkrumah University of Science and Technology — Ghana Kwame Nkrumah Universit… 1 author Institute of Cellular and Organismic Biology — Taiwan Institute of Cellular a… 1 author University of São Paulo — Brazil University of São Paulo 1 author Prof. Kwame Mensah — corresponding author KM Prof. Kwame Mensah ✉ Dr. Mei-Ling Zhou MZ Dr. Mei-Ling Zhou Dr. Mateo Silveira MS Dr. Mateo Silveira

Readership

123 reads over 3 months.

#4 most read in this journal this month
September 2026 November 2026

Bibliographic Information

Prof. Kwame Mensah, Dr. Mei-Ling Zhou, Dr. Mateo Silveira, (2026). Biocatalytic Enantioselective Synthesis of Chiral Amines Using Immobilized Transaminases in a Microfluidic Reactor System for Pharmaceutical Precursors, Journal of Ongoing Biosciences, 1(2): 117-123
Bibtex Citation
@article{prof._kwame_mensah2026jobs,
author = {Prof. Kwame Mensah and Dr. Mei-Ling Zhou and Dr. Mateo Silveira},
title = {Biocatalytic Enantioselective Synthesis of Chiral Amines Using Immobilized Transaminases in a Microfluidic Reactor System for Pharmaceutical Precursors},
journal = {Journal of Ongoing Biosciences},
year = {2026},
volume = {1},
number = {2},
pages = {117-123},
doi = {},
url = {https://scimatic.org/show_manuscript/10270}
}
APA Citation
Mensah, P.K., Zhou, D.M., Silveira, D.M., (2026). Biocatalytic Enantioselective Synthesis of Chiral Amines Using Immobilized Transaminases in a Microfluidic Reactor System for Pharmaceutical Precursors. Journal of Ongoing Biosciences, 1(2), 117-123. https://doi.org/

Author Information

  • To change your profile photo, login to scimatic.org, go to your profile and change the photo.
  • Any photo that shows your face will do: we crop it to your head and shoulders and give it a plain background automatically.
  • To sign in, go to Sign in and enter the e-mail address registered with the article: we e-mail you a one-time sign-in link (there is no password).
  • In case of any other problem, contact your editor directly or write to us at info @ scimatic.org